HER2-Positive Metastatic Breast Cancer: What’s New in Treatment & Quality-of-Life

Listen Now

Topics Covered

• HER2-Positive Metastatic Breast Cancer, in the Context of COVID-19
• Biomarker, Genomic & Diagnostic Testing: Grade & Hormone Receptors
• Standard Treatment Options, including Targeted Therapy
• How Biomarker Testing Informs Treatment Decisions
• New & Emerging Targeted Treatments
• Updates on Investigational New Drugs in Clinical Trials
• How Research Contributes to Your Treatment Options
• What’s New in the Prevention & Management of Treatment Side Effects, Symptoms, Discomfort, Neuropathy, Pain & Long-Term Effects
• The Increasing Role of Telemedicine/Telehealth Appointments
• Guidelines to Prepare for Telemedicine/Telehealth Appointments, including Technology, List of Questions & OpenNotes Discussion
• Key Questions to Ask Your Health Care Team about Quality-of-Life Concerns
• Questions for Our Panel of Experts

Our Panel of Experts

Generosa Grana, MD, FACP

Medical Director, MD Anderson Cancer Center at Cooper, The Cooper Health System, Professor of Medicine, Cooper Medical School at Rowan University

Saranya Chumsri, MD

Associate Professor of Medicine, Jacoby Center for Breast Health, Mayo Clinic Cancer Center, Jacksonville, FL

Paolo Tarantino, MD

Research Fellow, Dana-Farber Cancer Institute, Harvard Medical School, Medical Oncology Fellow, European Institute of Oncology, University of Milan

Lauren Chatalian, MSW

Director of Advocacy, CancerCare

Carolyn Messner, DSW, BCD, FAPOS, FAOSW

Senior Director of Education and Training, CancerCare

Brochure

You can download the brochure for this workshop

Workshop Date

This workshop was originally recorded on June 29, 2022.